Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction

被引:52
作者
Gibson, CM
Murphy, SA
Morrow, DA
Aroesty, JM
Gibbons, RJ
Gourlay, SG
Barron, HV
Giugliano, RP
Antman, EM
Braunwald, E
机构
[1] Brigham & Womens Hosp, Dept Med, TIMI Study Grp, Boston, MA 02115 USA
[2] Mayo Clin, Div Cardiovasc, Rochester, MN USA
[3] Univ Calif San Francisco, Div Cardiovasc, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.ahj.2003.12.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Both epicardial and myocardial perfusion have been associated with clinical outcomes in the setting of ST elevation myocardial infarction (STEMI), and the performance of adjunctive/rescue percutaneous coronary intervention (PCI) may further improve clinical outcomes after fibrinolytic administration. Methods The goal was to develop a simple, broadly applicable angiographic metric that takes into account indices of epicardial and myocardial perfusion both before and after PCI to arrive at a single perfusion grade in patients undergoing cardiac catheterization after fibrinolysis. The angiographic perfusion score (APS) is the sum of the Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG; 0-3) added to the TIMI myocardial perfusion grade (TMPG; 0-3) before and after PCI (total possible grade, 0-12). Failed perfusion was defined as an APS of 0 to 3, partial perfusion was defined as an APS of 4 to 9, and full perfusion was defined as an APS of 10 to 12. The APS was evaluated in patients from the Double-blind, Placebo-contolled, Multicenter Angiographic Trial of Rhumab CD18 in Acute Myocardial Infarction (LIMIT-AMI; n = 394) and Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction-Thrombolysis In Myocardial Infarction (ENTIRE-TIMI) 23 trials (n = 483), and infarct size (120-216 hours after AMI SPECT Technetium-99m Sestamibi data) was assessed in the LIMIT-AMI trial. Results The APS was associated with the incidence of death or myocardial infarction (failed, 16.7% [n = 18]; partial, 2.5% [n = 155]; full, 2.4% [n = 82]; P=.039 for trend) and larger SPECT infarct sizes (failed, median 39% [n = 10]; partial, 12% [n = 79]; and full, 8% [n 35]; P =.002). No patient with full APS died, whereas the mortality rate was 11.1% in patients with a failed APS (P=.03). Conclusions The APS combines grades of epicardial and tissue level perfusion before and after PCI or at the end of diagnostic cardiac catheterization to arrive at a single angiographic variable that is associated with infarct size and the rates of 30-day death or MI. Partial or full angiographic perfusion scores are associated with a halving of infarct size, and no patients with full angiographic perfusion died.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 23 条
[1]   TIMI PERFUSION GRADE-3 BUT NOT GRADE-2 RESULTS IN IMPROVED OUTCOME AFTER THROMBOLYSIS FOR MYOCARDIAL-INFARCTION - VENTRICULOGRAPHIC, ENZYMATIC, AND ELECTROCARDIOGRAPHIC EVIDENCE FROM THE TEAM-3 STUDY [J].
ANDERSON, JL ;
KARAGOUNIS, LA ;
BECKER, LC ;
SORENSEN, SG ;
MENLOVE, RL .
CIRCULATION, 1993, 87 (06) :1829-1839
[2]   Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction - Results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial [J].
Antman, EM ;
Louwerenburg, HW ;
Baars, HF ;
Wesdorp, JCL ;
Hamer, B ;
Bassand, JP ;
Bigonzi, F ;
Pisapia, G ;
Gibson, CM ;
Heidbuchel, H ;
Braunwald, E ;
Van de Werf, F .
CIRCULATION, 2002, 105 (14) :1642-1649
[3]   Double-blind, randomized trial of an Anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction - Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study [J].
Baran, KW ;
Nguyen, M ;
McKendall, GR ;
Lambrew, CT ;
Dykstra, G ;
Palmeri, ST ;
Gibbons, RJ ;
Borzak, S ;
Sobel, BE ;
Gourlay, SG ;
Rundle, AC ;
Gibson, CM ;
Barron, HV .
CIRCULATION, 2001, 104 (23) :2778-2783
[4]   RESIDUAL FLOW TO THE INFARCT ZONE AS A DETERMINANT OF INFARCT SIZE AFTER DIRECT ANGIOPLASTY [J].
CLEMENTS, IP ;
CHRISTIAN, TF ;
HIGANO, ST ;
GIBBONS, RJ ;
GERSH, BJ .
CIRCULATION, 1993, 88 (04) :1527-1533
[5]   Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis [J].
Dibra, A ;
Mehilli, J ;
Dirschinger, J ;
Pache, J ;
Neverve, J ;
Schwaiger, M ;
Schömig, A ;
Kastrati, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) :925-929
[6]   RANDOMIZED COMPARISON OF RESCUE ANGIOPLASTY WITH CONSERVATIVE MANAGEMENT OF PATIENTS WITH EARLY FAILURE OF THROMBOLYSIS FOR ACUTE ANTERIOR MYOCARDIAL-INFARCTION [J].
ELLIS, SG ;
DASILVA, ER ;
HEYNDRICKX, G ;
TALLEY, JD ;
CERNIGLIARO, C ;
STEG, G ;
SPAULDING, C ;
NOBUYOSHI, M ;
ERBEL, R ;
VASSANELLI, C ;
TOPOL, EJ .
CIRCULATION, 1994, 90 (05) :2280-2284
[7]   Infarct size measured by single photon emission computed tomographic imaging with 99mTc-sestamibi -: A measure of the efficacy of therapy in acute myocardial infarction [J].
Gibbons, RJ ;
Miller, TD ;
Christian, TF .
CIRCULATION, 2000, 101 (01) :101-108
[8]   Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs [J].
Gibson, CM ;
Cannon, CP ;
Murphy, SA ;
Ryan, KA ;
Mesley, R ;
Marble, SJ ;
McCabe, CH ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 2000, 101 (02) :125-130
[9]   TIMI frame count: A quantitative method of assessing coronary artery flow [J].
Gibson, CM ;
Cannon, CP ;
Daley, WL ;
Dodge, JT ;
Alexander, B ;
Marble, SJ ;
McCabe, CH ;
Raymond, L ;
Fortin, T ;
Poole, WK ;
Braunwald, E .
CIRCULATION, 1996, 93 (05) :879-888
[10]   Relationship between TIMI frame count and clinical outcomes after thrombolytic administration [J].
Gibson, CM ;
Murphy, SA ;
Rizzo, MJ ;
Ryan, KA ;
Marble, SJ ;
McCabe, CH ;
Cannon, CP ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 1999, 99 (15) :1945-1950